Effects of extended-release 7-nitroindazole gel formulation treatment on the behavior of Shank3 mouse model of autism

Medicine & Life Sciences

• 7-nitroindazole 100%
• Poly(sebacic acid-co-ricinoleic acid) 89%
• Autism Spectrum Disorder 68%
• Autistic Disorder 66%
• Gels 54%
• Interpersonal Relations 27%
• Anxiety 19%
• Nitrosative Stress 18%
• 3-nitrotyrosine 16%
• Nitric Oxide Synthase Type I 16%
• Protein S 16%
• Neurodevelopmental Disorders 15%
• Injections 15%
• Intraperitoneal Injections 13%
• Pharmaceutical Preparations 10%
• Therapeutic Uses 10%
• Therapeutics 10%
• Nitric Oxide 10%
• Communication 9%
• Memory 9%
• Phenotype 7%
• Mutation 7%
• Animals 6%

Chemistry

• Disorder 56%
• Gel 41%
• 3-Nitrotyrosine 16%
• Nitric Oxide Synthase Inhibitor 16%
• Intraperitoneal 14%
• Plasma Level 13%
• Drug 11%
• Acid 11%
• Nitric Oxide 10%
• Communication 10%
• Indicator 9%
• Mutation 9%
• Dose 8%
• Plasma 6%
• Reduction 5%
• Protein 4%